Yu Tian Wang

This inventor holds 8 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignees: The University of British Columbia, Qingdao Primedicine Pharmaceutical Company, Ltd., University of Saskatchewan. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yu Tian Wang. Retrieved from https://idiyas.com/inventor/yu-tian-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 8 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 6(Granted Patents)

Company Filing History:

6 out of 963

The University of British Columbia

patents

1 out of 1

Qingdao Primedicine Pharmaceutical Company, Ltd.

patent

1 out of 213

University of Saskatchewan

patents

Years Active: 2015-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12428456 - Peptide directed protein knockdown (2025-09-30),

2. 11186620 - Peptide directed protein knockdown (2021-11-30),

3. 11166924 - N-methyl-d-aspartate receptor allosteric modulators and methods for their use (2021-11-09),

4. 11117939 - Polypeptides and antibodies to treat skin conditions associated with overproduction of sebum (2021-09-14),

5. 10287333 - Peptide directed protein knockdown (2019-05-14),

6. 10258666 - Inhibitors of phosphatase and tensin homolog (PTEN) compositions, uses and methods (2019-04-16),

7. 9486472 - Methods for modulating neuronal responses (2016-11-08),

8. 9127079 - Inhibitors of phosphatase and tensin homolog (PTEN) conjugates (2015-09-08),

Title: Yu Tian Wang: Innovator in Peptide Research

Introduction

Yu Tian Wang is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of peptide research, holding a total of 8 patents. His work focuses on innovative methods for protein knockdown, which have potential applications in treating various diseases.

Latest Patents

One of Yu Tian Wang's latest patents is centered around peptide-directed protein knockdown. This invention provides a peptide that includes a chaperone-mediated autophagy (CMA)-targeting signal domain, a protein-binding domain that selectively binds to a target cytosolic protein, and a cell membrane penetrating domain (CMPD). The invention outlines methods for reducing the intracellular expression level of an endogenous target protein both in vitro and in animal models. Furthermore, it offers methods for treating pathological conditions in animals, particularly neurodegenerative diseases. In one embodiment, the target cytosolic protein is death-associated protein kinase 1, and the CMPD is the protein transduction domain of the HIV-1 Tat protein.

Career Highlights

Yu Tian Wang has worked with notable institutions, including the University of British Columbia and Qingdao Primedicine Pharmaceutical Company, Ltd. His research has significantly advanced the understanding of peptide applications in medical science.

Collaborations

Yu Tian Wang has collaborated with esteemed colleagues such as Xuelai Fan and Jack Wuyang Jin. Their combined expertise has contributed to the success of various research projects.

Conclusion

Yu Tian Wang is a distinguished inventor whose work in peptide research has the potential to revolutionize treatments for neurodegenerative diseases. His innovative patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.